US3169967A
(en)
|
1957-11-14 |
1965-02-16 |
Ciba Geigy Corp |
Methyl o-lower alkanoyl-reserpates
|
US3037980A
(en)
|
1955-08-18 |
1962-06-05 |
Burroughs Wellcome Co |
Pyrrolopyrimidine vasodilators and method of making them
|
DE1770420U
(de)
|
1958-02-27 |
1958-07-17 |
Tara Union G M B H |
Blumentopf aus kunststoff.
|
US3506643A
(en)
|
1966-12-09 |
1970-04-14 |
Max Thiel |
N**6-aralkyl-adenosine derivatives
|
DE2139107A1
(de)
|
1971-08-04 |
1973-02-15 |
Merck Patent Gmbh |
Heterocyclisch substituierte adenosinverbindungen
|
US3814251A
(en)
|
1972-08-09 |
1974-06-04 |
Sperry Rand Corp |
Power transmission
|
US3962443A
(en)
|
1972-08-14 |
1976-06-08 |
Dainippon Pharmaceutical Co., Ltd. |
Antibacterial pharmaceutical compositions and processes for preparation thereof
|
DE2248232A1
(de)
|
1972-10-02 |
1974-04-11 |
Basf Ag |
4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
AR204003A1
(es)
|
1973-04-03 |
1975-11-12 |
Dainippon Pharmaceutical Co |
Procedimiento para preparar compuestos derivados del acido 2-(1-piperazinil)-5-oxopirido-(2,3-d)pirimidino-6-carboxilico y sus sales farmaceuticamente aceptables
|
US3862189A
(en)
|
1973-08-14 |
1975-01-21 |
Warner Lambert Co |
Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
|
US3936454A
(en)
|
1973-08-14 |
1976-02-03 |
Warner-Lambert Company |
5-Amino-4-chloro-6-(substituted amino)-pyrimidines
|
DK3375A
(pt)
|
1974-01-25 |
1975-09-15 |
Ciba Geigy Ag |
|
JPS587626B2
(ja)
|
1974-02-13 |
1983-02-10 |
大日本製薬株式会社 |
ナフチリジン オヨビ キノリンユウドウタイノセイホウ
|
JPS50111080U
(pt)
|
1974-02-21 |
1975-09-10 |
|
|
JPS5625234Y2
(pt)
|
1976-01-17 |
1981-06-15 |
|
|
JPS5359663A
(en)
|
1976-11-09 |
1978-05-29 |
Sumitomo Chem Co Ltd |
2-halogeno methyl indole derivatives and process for praparation of the same
|
JPS52106897A
(en)
|
1977-01-10 |
1977-09-07 |
Dainippon Pharmaceut Co Ltd |
Synthesis of piperazine derivatives
|
JPS5392767A
(en)
|
1977-01-27 |
1978-08-15 |
Sumitomo Chem Co Ltd |
Preparation of 2-phthalimidomethylindole derivatives
|
JPS5625234A
(en)
|
1979-08-02 |
1981-03-11 |
Hitachi Denshi Ltd |
Dropout display system
|
JPS56123981U
(pt)
|
1980-02-20 |
1981-09-21 |
|
|
JPS56123981A
(en)
|
1981-02-23 |
1981-09-29 |
Dainippon Pharmaceut Co Ltd |
Preparation of 1,4-disubstituted piperazine
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
JPS5883698U
(ja)
|
1981-11-27 |
1983-06-06 |
石川島播磨重工業株式会社 |
熱交換器
|
JPS58162949A
(ja)
|
1982-03-20 |
1983-09-27 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS60140373U
(ja)
|
1984-02-28 |
1985-09-17 |
東洋ハ−ネス株式会社 |
ワイヤハ−ネスのア−ス構造
|
JPS6190153A
(ja)
|
1984-10-09 |
1986-05-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPS62103640A
(ja)
|
1985-07-18 |
1987-05-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS62103640U
(pt)
|
1985-12-18 |
1987-07-02 |
|
|
JPH07119970B2
(ja)
|
1986-04-18 |
1995-12-20 |
富士写真フイルム株式会社 |
画像形成方法
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
CA1324609C
(en)
|
1986-07-30 |
1993-11-23 |
Eastman Kodak Company |
Photographic element and process
|
US4861701A
(en)
|
1987-10-05 |
1989-08-29 |
Eastman Kodak Company |
Photographic element and process comprising a compound which comprises two timing groups in sequence
|
AT388372B
(de)
|
1987-10-08 |
1989-06-12 |
Tanabe Seiyaku Co |
Neue naphthalinderivate und sie enthaltende pharmazeutika
|
JPH01250316A
(ja)
|
1987-12-28 |
1989-10-05 |
Tanabe Seiyaku Co Ltd |
抗脂血剤
|
EP0364598A4
(en)
|
1988-03-02 |
1992-01-15 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3,4-dihydrothieno 2,3-d¨pyrimidine compounds and pharmaceutical application thereof
|
US5208250A
(en)
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
CA2053863C
(en)
|
1990-04-25 |
1996-10-29 |
Keizo Tanikawa |
Pyridazinone derivatives
|
SU1712359A1
(ru)
|
1990-05-07 |
1992-02-15 |
Уфимский Нефтяной Институт |
Гидрохлорид 8 @ -гидроксихинолинового эфира 8-гидроксихинолин-7-карбоновой кислоты, в качестве бактерицида дл подавлени сульфатвосстанавливающих бактерий и культур РSеUDомоNаS и АRтнRовастеR
|
DE69129389T2
(de)
|
1990-06-28 |
1998-10-08 |
Fuji Photo Film Co Ltd |
Photographische Silberhalogenidmaterialien
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
HUT64064A
(en)
|
1992-02-13 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
WO1993022291A1
(en)
|
1992-04-24 |
1993-11-11 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal and fungicidal aminopyrimidines
|
TW229140B
(pt)
|
1992-06-05 |
1994-09-01 |
Shell Internat Res Schappej B V |
|
FR2714907B1
(fr)
|
1994-01-07 |
1996-03-29 |
Union Pharma Scient Appl |
Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
JPH0987282A
(ja)
|
1995-09-21 |
1997-03-31 |
Kyowa Hakko Kogyo Co Ltd |
チアゾール誘導体
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
JPH09176116A
(ja)
|
1995-12-27 |
1997-07-08 |
Toray Ind Inc |
複素環誘導体およびその医薬用途
|
JPH1025294A
(ja)
|
1996-03-26 |
1998-01-27 |
Akira Matsuda |
縮合ヘテロ環誘導体、その製造法及びそれを含有する悪性腫瘍治療剤
|
EP0934307B1
(en)
|
1996-06-19 |
2011-04-27 |
Aventis Pharma Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
ATE283855T1
(de)
|
1996-07-03 |
2004-12-15 |
Sumitomo Pharma |
Neue purinderivate
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
JPH10231297A
(ja)
|
1997-02-20 |
1998-09-02 |
Japan Energy Corp |
新規なアデニン−1−n−オキシド誘導体およびその医薬用途
|
KR100540046B1
(ko)
|
1997-11-12 |
2006-01-10 |
미쓰비시 가가꾸 가부시키가이샤 |
퓨린유도체 및 이를 유효성분으로 함유하는 의약
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
IL137718A0
(en)
|
1998-02-25 |
2001-10-31 |
Genetics Inst |
Inhibitors of phospholipase enzymes
|
IL137540A0
(en)
|
1998-02-25 |
2001-07-24 |
Genetics Inst |
Inhibitors of phospholipase a2
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
PL346840A1
(en)
|
1998-05-04 |
2002-02-25 |
Zentaris Ag |
Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
|
US6673797B1
(en)
|
1998-05-26 |
2004-01-06 |
Chugai Seiyaku Kabushiki Kaisha |
Heterocyclic indole derivatives and mono- or diazaindole derivatives
|
JP3997651B2
(ja)
|
1998-06-24 |
2007-10-24 |
コニカミノルタホールディングス株式会社 |
新規色素及び画像記録材料及び感熱転写材料及びインクジェット記録液
|
DE69942097D1
(de)
|
1998-08-11 |
2010-04-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
CA2341506A1
(en)
|
1998-08-25 |
2000-03-02 |
The Uab Research Foundation |
Inhibitors of bacterial nad synthetase
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
KR20010093308A
(ko)
|
1999-02-01 |
2001-10-27 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
사이클린 의존성 키나제 2 및 Iκ-Aα의 퓨린 억제제
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US6436965B1
(en)
|
2000-03-02 |
2002-08-20 |
Merck Frosst Canada & Co. |
PDE IV inhibiting amides, compositions and methods of treatment
|
EP1138328A1
(en)
|
2000-03-29 |
2001-10-04 |
Eli Lilly And Company Limited |
Naphthalene derivatives as CNS drugs
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
PT1294358E
(pt)
|
2000-06-28 |
2004-12-31 |
Smithkline Beecham Plc |
Processo de moagem por via humida
|
CN1331340A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人拓扑异构酶12.1和编码这种多肽的多核苷酸
|
PT1300398E
(pt)
|
2000-07-05 |
2006-07-31 |
Astellas Pharma Inc |
Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
|
FR2814073B1
(fr)
|
2000-09-21 |
2005-06-24 |
Yang Ji Chemical Company Ltd |
Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
|
DOP2002000334A
(es)
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
KR20030078958A
(ko)
|
2001-03-01 |
2003-10-08 |
시오노기세이야쿠가부시키가이샤 |
Hiv 인테그라제 저해 활성을 갖는 질소 함유의헤테로아릴 화합물
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US7034030B2
(en)
|
2001-03-30 |
2006-04-25 |
Smithkline Beecham Corporation |
Pyralopyridines, process for their preparation and use as therapeutic compounds
|
JP2004525150A
(ja)
|
2001-03-30 |
2004-08-19 |
スミスクライン ビーチャム コーポレーション |
治療用化合物としてのピラゾロピリジン類の使用
|
US6962914B2
(en)
|
2001-04-27 |
2005-11-08 |
Smithkline Beecham Corporation |
Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
|
CZ294535B6
(cs)
|
2001-08-02 |
2005-01-12 |
Ústav Experimentální Botaniky Avčr |
Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
AU2002337142B2
(en)
|
2001-09-19 |
2007-10-11 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
CN1578780A
(zh)
|
2001-09-26 |
2005-02-09 |
拜尔药品公司 |
用作抗糖尿病药物的1,6-萘啶衍生物
|
ES2309206T3
(es)
|
2001-10-02 |
2008-12-16 |
Smithkline Beecham Corporation |
Compuestos quimicos.
|
JP4959918B2
(ja)
|
2001-10-30 |
2012-06-27 |
ノバルティス アーゲー |
Flt3レセプター・チロシン・キナーゼ活性インヒビターとしてのスタウロスポリン誘導体
|
WO2003041642A2
(en)
|
2001-11-09 |
2003-05-22 |
Enzon, Inc. |
Polymeric thiol-linked prodrugs employing benzyl elimination systems
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
DE60222302T2
(de)
|
2001-12-06 |
2008-05-29 |
Merck & Co., Inc. |
Inhibitoren von mitotischem kinesin
|
EP1551812B1
(en)
|
2001-12-06 |
2009-03-04 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
TW200301135A
(en)
|
2001-12-27 |
2003-07-01 |
Otsuka Maryland Res Inst Inc |
Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
|
CA2476162A1
(en)
|
2002-02-13 |
2003-08-21 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
US20050049267A1
(en)
|
2002-03-01 |
2005-03-03 |
Pintex Pharmaceuticals, Inc. |
Pin1-modulating compounds and methods of use thereof
|
AU2003222106A1
(en)
|
2002-04-03 |
2003-10-20 |
Bristol-Myers Squibb Company |
Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
|
RU2004135392A
(ru)
|
2002-05-06 |
2005-06-27 |
Дженелэбс Текнолоджиз, Инк. (Us) |
Производные нуклеозидов для лечения инфекции, вызываемой вирусом гепатита с
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
EP2045242A1
(en)
|
2002-08-13 |
2009-04-08 |
Shionogi&Co., Ltd. |
Heterocyclic compounds having inhibitory activity against HIV integrase
|
JP4190232B2
(ja)
|
2002-08-26 |
2008-12-03 |
富士通株式会社 |
機械研磨を行う方法
|
WO2004029054A1
(ja)
|
2002-09-27 |
2004-04-08 |
Sumitomo Pharmaceuticals Company, Limited |
新規アデニン化合物及びその用途
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
ATE527250T1
(de)
|
2002-11-21 |
2011-10-15 |
Novartis Ag |
2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
|
JP4544999B2
(ja)
|
2002-11-25 |
2010-09-15 |
持田製薬株式会社 |
4−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
EP1577288B1
(en)
|
2002-12-26 |
2014-07-23 |
Eisai R&D Management Co., Ltd. |
Selective estrogen receptor modulators
|
CZ294538B6
(cs)
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
RU2233842C1
(ru)
|
2003-01-13 |
2004-08-10 |
Петров Владимир Иванович |
Производные пурина, обладающие противовирусной активностью
|
AR043692A1
(es)
|
2003-02-06 |
2005-08-10 |
Novartis Ag |
2-cianopirrolopirimidinas y sus usos farmaceuticos
|
GB0304640D0
(en)
|
2003-02-28 |
2003-04-02 |
Novartis Ag |
Organic compounds
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
US20060247245A1
(en)
|
2003-05-05 |
2006-11-02 |
Yuelian Xu |
Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
|
KR20060069356A
(ko)
|
2003-06-20 |
2006-06-21 |
카이론 코포레이션 |
항암제로서 피리디노[1,2-α]피리미딘-4-온 화합물
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
JP4570015B2
(ja)
|
2003-07-14 |
2010-10-27 |
クミアイ化学工業株式会社 |
2−イソオキサゾリン誘導体及びそれを有効成分として含有する除草剤
|
US20050124637A1
(en)
|
2003-08-15 |
2005-06-09 |
Irm Llc |
Compounds and compositions as inhibitors of receptor tyrosine kinase activity
|
US7129244B2
(en)
|
2003-09-18 |
2006-10-31 |
Conforma Therapeutics Corporation |
Triazolopyrimidines and related analogs as HSP90-inhibitors
|
CA2539853C
(en)
|
2003-09-23 |
2011-04-19 |
Merck & Co., Inc. |
Isoquinolinone potassium channel inhibitors
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
WO2005074603A2
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
EP1717238A4
(en)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
FUNGICIDES HETEROCYCLIC COMPOUNDS
|
WO2005091857A2
(en)
|
2004-03-12 |
2005-10-06 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine and 1,8-naphthyridine derivatives and their use to treat diabetes and related disorders
|
CN1560035A
(zh)
|
2004-03-12 |
2005-01-05 |
沈阳药科大学 |
5-羟基吲哚-3-羧酸脂类衍生物
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
8−オキソアデニン化合物
|
AU2005231440B9
(en)
|
2004-04-02 |
2012-02-23 |
Dogwood Pharmaceuticals, Inc. |
Selective antagonists of A2A adenosine receptors
|
CN102229609A
(zh)
|
2004-05-13 |
2011-11-02 |
艾科斯有限公司 |
作为人磷脂酰肌醇3-激酶δ抑制剂的喹唑啉酮
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
EP1773830A1
(en)
|
2004-07-22 |
2007-04-18 |
AstraZeneca AB |
Fused pyrimidones useful in the treatment and the prevention of cancer
|
CA2575188A1
(en)
|
2004-08-18 |
2006-02-23 |
Astrazeneca Ab |
Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
EP2275412A1
(en)
|
2004-10-19 |
2011-01-19 |
Novartis Vaccines and Diagnostics, Inc. |
Indole and benzimidazole derivatives
|
WO2006052546A2
(en)
|
2004-11-04 |
2006-05-18 |
Neurogen Corporation |
Pyrazolylmethyl heteroaryl derivatives
|
WO2006068760A2
(en)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Anti-inflammatory pyrazolopyrimidines
|
EP1885352A2
(en)
|
2004-11-24 |
2008-02-13 |
Novartis AG |
Combinations comprising jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors
|
AU2006214190A1
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
WO2007002701A2
(en)
|
2005-06-27 |
2007-01-04 |
Amgen Inc. |
Anti-inflammatory aryl nitrile compounds
|
FR2889192A1
(fr)
|
2005-07-27 |
2007-02-02 |
Cytomics Systems Sa |
Composes antifongiques, compositions contenant ces composes et leurs utilisations
|
WO2007022371A2
(en)
|
2005-08-16 |
2007-02-22 |
Genzyme Corporation |
Chemokine receptor binding compounds
|
US7642270B2
(en)
|
2005-09-14 |
2010-01-05 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
|
US20090118263A1
(en)
|
2005-09-22 |
2009-05-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Adenine Compound
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
RU2597364C2
(ru)
|
2005-11-01 |
2016-09-10 |
Таргеджен, Инк. |
Би-арил-мета-пиримидиновые ингибиторы киназ
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
DK1954274T3
(da)
|
2005-11-10 |
2011-01-31 |
Chemocentryx Inc |
Substituerede quinoloner og fremgangsmåder til anvendelse
|
WO2007070514A1
(en)
|
2005-12-13 |
2007-06-21 |
Incyte Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
EP1984375A2
(en)
|
2006-01-25 |
2008-10-29 |
Smithkline Beecham Corporation |
Chemical compounds
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
JPWO2007102392A1
(ja)
|
2006-03-03 |
2009-07-23 |
塩野義製薬株式会社 |
Mmp−13選択的阻害剤
|
EA200870385A1
(ru)
|
2006-03-29 |
2009-04-28 |
Фолдркс Фармасьютикалз, Инк. |
Ингибирование токсичности альфа-синуклеина
|
KR20090017498A
(ko)
*
|
2006-04-04 |
2009-02-18 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
Pi3 키나제 길항물질
|
DE102006029074A1
(de)
*
|
2006-06-22 |
2007-12-27 |
Friedrich-Schiller-Universität Jena |
4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
US20080004253A1
(en)
|
2006-06-30 |
2008-01-03 |
Bryan James Branstetter |
Thiazolopyrimidine modulators of TRPV1
|
US20080009508A1
(en)
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
EP2046788A1
(en)
|
2006-07-12 |
2009-04-15 |
Syngeta Participations AG |
Triazolopyridine derivatives as herbicides
|
RU2448109C2
(ru)
|
2006-08-08 |
2012-04-20 |
Чугаи Сейяку Кабусики Кайся |
Производное пиримидина в качестве ингибитора pi3k и его применение
|
JP5336375B2
(ja)
|
2006-08-30 |
2013-11-06 |
セルゾーム リミテッド |
キナーゼ阻害剤としてのトリアゾール誘導体
|
WO2008032033A1
(en)
|
2006-09-14 |
2008-03-20 |
Astrazeneca Ab |
4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
|
EP1972631A1
(en)
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
WO2008055013A2
(en)
|
2006-10-31 |
2008-05-08 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase
|
WO2008064018A1
(en)
|
2006-11-13 |
2008-05-29 |
Eli Lilly & Co. |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
PL2099447T3
(pl)
|
2006-11-22 |
2013-06-28 |
Incyte Holdings Corp |
Imidazotriazyny i imidazopirmidyny jako inhibitory kinaz
|
WO2008082490A2
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
CN101589046B
(zh)
|
2006-12-29 |
2011-09-21 |
弗·哈夫曼-拉罗切有限公司 |
氮杂螺环衍生物
|
MX2009008338A
(es)
|
2007-02-05 |
2009-08-12 |
Xenon Pharmaceuticals Inc |
Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio.
|
CA2676906A1
(en)
|
2007-02-12 |
2008-08-21 |
Intermune, Inc. |
Novel inhibitors hepatitis c virus replication
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
US20080233127A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
|
CA2680783C
(en)
|
2007-03-23 |
2012-04-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
CA2681136C
(en)
|
2007-03-23 |
2012-05-22 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
JP2010531304A
(ja)
|
2007-06-18 |
2010-09-24 |
ユニバーシティ オブ ルイビル リサーチ ファウンデーション、インコーポレイテッド |
抗悪性腫瘍活性を有するpfkfb3阻害物質ファミリー
|
NZ582090A
(en)
|
2007-06-29 |
2012-05-25 |
Gilead Sciences Inc |
Purine derivatives and their use as modulators of toll-like receptor 7
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
JP2009076865A
(ja)
|
2007-08-29 |
2009-04-09 |
Fujifilm Corp |
有機電界発光素子
|
TW200916447A
(en)
|
2007-08-29 |
2009-04-16 |
Methylgene Inc |
Sirtuin inhibitors
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
JP2009080233A
(ja)
|
2007-09-26 |
2009-04-16 |
Kyocera Mita Corp |
電子写真感光体
|
CZ300774B6
(cs)
|
2007-10-05 |
2009-08-05 |
Univerzita Palackého |
Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
|
WO2009062118A2
(en)
|
2007-11-07 |
2009-05-14 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
WO2009063235A1
(en)
|
2007-11-13 |
2009-05-22 |
Astrazeneca Ab |
Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018
|
JP2009120686A
(ja)
|
2007-11-14 |
2009-06-04 |
Toyo Ink Mfg Co Ltd |
光重合開始剤、重合性組成物、および重合物の製造方法。
|
CA2710194C
(en)
|
2007-12-19 |
2014-04-22 |
Amgen Inc. |
Inhibitors of p13 kinase
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
ES2587738T3
(es)
|
2007-12-21 |
2016-10-26 |
Ucb Biopharma Sprl |
Derivados de quinoxalina y quinolina como inhibidores de quinasa
|
WO2009086123A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth |
Imidazo [1,2-a] pyridine compounds
|
BRPI0722222A2
(pt)
|
2007-12-28 |
2015-06-16 |
Topharman Shangai Co Ltd |
N-{1-[3-(2-etóxi-5-(4-etilpiperazinil)sulfonilfenil)-4,5-di hidro-5-oxo-1,2,4-triazina-6-il]etil}butiramida, seu método de preparo e seu uso
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
US8193182B2
(en)
*
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
NZ586642A
(en)
|
2008-01-11 |
2012-04-27 |
Natco Pharma Ltd |
Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
WO2009097446A1
(en)
|
2008-01-30 |
2009-08-06 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
EP2444403A1
(en)
|
2008-04-18 |
2012-04-25 |
Shionogi Co., Ltd. |
Heterocyclic compound having inhibitory activity on PI3K
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
WO2009140215A2
(en)
|
2008-05-11 |
2009-11-19 |
Geraghty, Erin |
Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
|
EP2300005A4
(en)
|
2008-05-28 |
2011-07-13 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of U S Army Medical Res And Mate |
Small-molecule inhibitors of botulinum neurotoxins
|
WO2010008739A2
(en)
|
2008-06-20 |
2010-01-21 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
US8026271B2
(en)
|
2008-07-11 |
2011-09-27 |
National Health Research Institutes |
Formulations of indol-3-yl-2-oxoacetamide compounds
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
EP2346508B1
(en)
|
2008-09-26 |
2016-08-24 |
Intellikine, LLC |
Heterocyclic kinase inhibitors
|
SG195655A1
(en)
|
2008-11-13 |
2013-12-30 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
EP2379547A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
NZ593418A
(en)
|
2008-12-24 |
2013-10-25 |
Bial Portela & Ca Sa |
Imidazole compounds for use as enzyme inhibitors
|
WO2010083444A1
(en)
|
2009-01-15 |
2010-07-22 |
Anvyl, Llc |
Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
|
US8513284B2
(en)
|
2009-02-13 |
2013-08-20 |
Ucb Pharma, S.A. |
Fused pyridine and pyrazine derivatives as kinase inhibitors
|
AU2010232642A1
(en)
|
2009-03-31 |
2011-10-20 |
Arqule, Inc. |
Substituted indolo-piperidine compounds
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
PT2421536E
(pt)
|
2009-04-20 |
2015-10-20 |
Gilead Calistoga Llc |
Métodos de tratamento para tumores sólidos
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
AU2010249380B2
(en)
|
2009-05-22 |
2015-08-20 |
Incyte Holdings Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors
|
UY32743A
(es)
|
2009-06-25 |
2010-12-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
WO2010151735A2
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
TWI691493B
(zh)
|
2009-06-29 |
2020-04-21 |
美商阿吉歐斯製藥公司 |
治療化合物及組成物
|
PL2448938T3
(pl)
|
2009-06-29 |
2014-11-28 |
Incyte Holdings Corp |
Pirymidynony jako inhibitory PI3K
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
BR112012001325A2
(pt)
|
2009-07-21 |
2017-05-02 |
Gilead Calistoga Llc |
tratamento de distúrbios do fígado com inibidaores de pi3k
|
DK2470546T3
(da)
|
2009-08-28 |
2013-10-14 |
Takeda Pharmaceutical |
HEXAHYDROOXAZINOPTERIDIN- forbindelser til anvendelse som mTOR INHIBITORER
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
TW201125867A
(en)
|
2009-10-20 |
2011-08-01 |
Cellzome Ltd |
Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
SG10201500895XA
(en)
|
2009-11-05 |
2015-04-29 |
Rhizen Pharmaceuticals Sa |
Chromen-4-one Derivatives As Kinase Modulators
|
JP5114610B1
(ja)
|
2009-11-10 |
2013-01-09 |
ファイザー・インク |
N1−ピラゾロスピロケトンアセチル−CoAカルボキシラーゼ阻害薬
|
EP2499126B1
(en)
|
2009-11-12 |
2015-01-07 |
UCB Pharma, S.A. |
Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
|
WO2011058111A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Aminopurine derivatives as kinase inhibitors
|
EP2511283A4
(en)
|
2009-12-10 |
2013-07-03 |
Inst Materia Medica Cams |
N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND THEIR USE
|
US8680108B2
(en)
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
WO2011075628A1
(en)
|
2009-12-18 |
2011-06-23 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
AU2010334804B2
(en)
*
|
2009-12-23 |
2015-04-02 |
Palau Pharma, S.L.U. |
Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
JP5781090B2
(ja)
|
2010-01-07 |
2015-09-16 |
ダウ アグロサイエンシィズ エルエルシー |
チアゾロ[5,4−d]ピリミジン及び農薬としてのそれらの使用
|
UY33199A
(es)
|
2010-01-26 |
2011-08-31 |
Boehringer Ingelheim Int |
5-alquinil-pirimidinas.
|
CN102985417B
(zh)
|
2010-03-10 |
2015-01-28 |
因塞特公司 |
作为jak1抑制剂的哌啶-4-基氮杂环丁烷衍生物
|
CN102802632A
(zh)
|
2010-03-22 |
2012-11-28 |
格兰马克药品股份有限公司 |
含有嘧啶酮衍生物的药物组合物
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
US9193721B2
(en)
|
2010-04-14 |
2015-11-24 |
Incyte Holdings Corporation |
Fused derivatives as PI3Kδ inhibitors
|
WO2011146882A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
JP2013528228A
(ja)
|
2010-06-11 |
2013-07-08 |
ギリアード カリストガ エルエルシー |
キナゾリノン化合物による選択した患者における血液系障害を処置する方法
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
AU2011271460B2
(en)
|
2010-07-01 |
2014-02-06 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of P13K activity
|
EP2588467A1
(en)
|
2010-07-01 |
2013-05-08 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
JP2013533884A
(ja)
|
2010-07-02 |
2013-08-29 |
アムジエン・インコーポレーテツド |
Pi3k活性阻害剤としての複素環化合物およびそれらの使用
|
JP2013540758A
(ja)
|
2010-09-24 |
2013-11-07 |
ギリアード カリストガ エルエルシー |
Pi3k阻害化合物のアトロプ異性体
|
EP2635565A1
(en)
|
2010-11-04 |
2013-09-11 |
Amgen Inc. |
5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
|
CN103298474B
(zh)
|
2010-11-10 |
2016-06-29 |
无限药品股份有限公司 |
杂环化合物及其用途
|
US8765768B2
(en)
|
2010-11-17 |
2014-07-01 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
EP2640725B1
(en)
|
2010-11-19 |
2015-01-07 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
TW201249845A
(en)
|
2010-11-19 |
2012-12-16 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
JP2014501261A
(ja)
|
2010-12-23 |
2014-01-20 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれらの使用
|
AR084824A1
(es)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
US9249087B2
(en)
|
2011-02-01 |
2016-02-02 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods using the same
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
WO2012177606A1
(en)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
KR101982475B1
(ko)
|
2011-09-02 |
2019-05-27 |
인사이트 홀딩스 코포레이션 |
Pi3k 억제제로서 헤테로시클릴아민
|
JP2014528451A
(ja)
|
2011-10-04 |
2014-10-27 |
ギリアード カリストガ エルエルシー |
Pi3kの新規キノキサリン阻害剤
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
MX2015005428A
(es)
|
2012-11-01 |
2015-07-21 |
Incyte Corp |
Derivados triciclicos fusionados de tiofeno como inhibidores de la cinasa janus (jak).
|
TWI657090B
(zh)
|
2013-03-01 |
2019-04-21 |
英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ 相關病症之用途
|
HUE058914T2
(hu)
|
2013-03-15 |
2022-09-28 |
Janssen Pharmaceutica Nv |
Gyógyszer elõállítására szolgáló eljárások és köztitermékek
|
ES2845210T3
(es)
|
2013-05-17 |
2021-07-26 |
Incyte Corp |
Derivados de bipirazol como inhibidores de JAK
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
TWI698436B
(zh)
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
|
ES2843522T3
(es)
|
2015-02-27 |
2021-07-19 |
Incyte Corp |
Sales del inhibidor de PI3K y procesos para su preparación
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
WO2016183062A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one
|
EP3801533A1
(en)
|
2018-06-01 |
2021-04-14 |
Incyte Corporation |
Dosing regimen for the treatment of pi3k related disorders
|